Evidence map›Paper›PMID 19362100›Full record

ReviewToxicology and applied pharmacology2009

Metallothionein protection of cadmium toxicity.

Curtis D Klaassen, Jie Liu, Bhalchandra A Diwan

Abstract readReview
In one paragraph

Review in Toxicology and applied pharmacology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 209 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
209citing papers in PubMed, 2 pooled it
26.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

209 citing papers in PubMed, 2 syntheses or guidelines pooled it, 723 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

149 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Curtis D KlaassenDepartment of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS 66160-7417, USA. cklaasse@kumc.edu
Jie Liu
Bhalchandra A Diwan
Research Triangle Park Foundation · USScience Applications International Corporation (United States) · USUniversity of Kansas Medical Center · US

Funding

Regulation of Hepatic Uptake of Endogenous Signaling Molecules and XenobioticsR01ES009649 · NIEHS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI CSANAKY, IVAN · 2000 to 2014
$4.0M
Regulation of Hepatic Excretion of Xenobiotics by MrpsR01ES009716 · NIEHS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI KLAASSEN, CURTIS DEAN · 2000 to 2010
$3.2M
Coordinate Regulation of Uptake and Efflux TransportersR01ES013714 · NIEHS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI KLAASSEN, CURTIS DEAN · 2006 to 2010
$1.7M
Intramural NIH HHSNCI NIH HHS N01 CO012400NIEHS NIH HHS ES-013714NIEHS NIH HHS ES-09649NIEHS NIH HHS ES-09716NIEHS NIH HHS R01 ES009649NIEHS NIH HHS R01 ES009716NIEHS NIH HHS R01 ES013714
6 · The paper itself

Abstract

The discovery of the cadmium (Cd)-binding protein from horse kidney in 1957 marked the birth of research on this low-molecular weight, cysteine-rich protein called metallothionein (MT) in Cd toxicology. MT plays minimal roles in the gastrointestinal absorption of Cd, but MT plays important roles in Cd retention in tissues and dramatically decreases biliary excretion of Cd. Cd-bound to MT is responsible for Cd accumulation in tissues and the long biological half-life of Cd in the body. Induction of MT protects against acute Cd-induced lethality, as well as acute toxicity to the liver and lung. Intracellular MT also plays important roles in ameliorating Cd toxicity following prolonged exposures, particularly chronic Cd-induced nephrotoxicity, osteotoxicity, and toxicity to the lung, liver, and immune system. There is an association between human and rodent Cd exposure and prostate cancers, especially in the portions where MT is poorly expressed. MT expression in Cd-induced tumors varies depending on the type and the stage of tumor development. For instance, high levels of MT are detected in Cd-induced sarcomas at the injection site, whereas the sarcoma metastases are devoid of MT. The use of MT-transgenic and MT-null mice has greatly helped define the role of MT in Cd toxicology, with the MT-null mice being hypersensitive and MT-transgenic mice resistant to Cd toxicity. Thus, MT is critical for protecting human health from Cd toxicity. There are large individual variations in MT expression, which might in turn predispose some people to Cd toxicity.

Indexed as

AnimalsCadmiumCell Transformation, NeoplasticEnvironmental PollutantsHumansMetallothioneinMiceNeoplasmsProtein BindingCadmiumEnvironmental PollutantsMetallothionein

Identifiers

PMID19362100
PMCPMC2740813
OpenAlexW1990208536

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.